163 related articles for article (PubMed ID: 34480811)
1. Kaposiform haemangioendothelioma in an adult: lack of response to topical sirolimus and response to radiotherapy.
Der Sarkissian SA; Wong XL; Kossard S; Hong A; Sebaratnam DF
Clin Exp Dermatol; 2022 Jan; 47(1):192-193. PubMed ID: 34480811
[TBL] [Abstract][Full Text] [Related]
2. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review.
Wang C; Li Y; Xiang B; Li F; Chen S; Li L; Ji Y
Pancreas; 2017; 46(5):e39-e41. PubMed ID: 28426496
[No Abstract] [Full Text] [Related]
3. A case of kaposiform haemangioendothelioma successfully and safely treated with sirolimus.
Wlodek C; Burt H; Shaw L
Clin Exp Dermatol; 2017 Oct; 42(7):825-827. PubMed ID: 28703334
[No Abstract] [Full Text] [Related]
4. The effect of topical sirolimus on superficial Kaposiform haemangioendothelioma.
Liu YX; Zhang J; Nie XL; Chen YL; Wang ZY; Xu ZG
Australas J Dermatol; 2021 May; 62(2):e329-e331. PubMed ID: 33216947
[No Abstract] [Full Text] [Related]
5. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
[TBL] [Abstract][Full Text] [Related]
7. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
8. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon.
Mariani LG; Schmitt IR; Garcia CD; Kiszewski AE
Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627
[No Abstract] [Full Text] [Related]
9. Decreased vascularization of retroperitoneal kaposiform hemangioendothelioma induced by treatment with sirolimus explains relief of symptoms.
Iacobas I; Simon ML; Amir T; Gribbin CE; McPartland TG; Kaufman MR; Calderwood S; Nosher JL
Clin Imaging; 2015; 39(3):529-32. PubMed ID: 25662209
[TBL] [Abstract][Full Text] [Related]
10. A Case of Superficial Kaposiform Hemangioendothelioma Treated with Oral Propranolol Combined with Topical Sirolimus.
Dang N; Ren Y
Vasc Health Risk Manag; 2024; 20():251-254. PubMed ID: 38883398
[TBL] [Abstract][Full Text] [Related]
11. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
Ji Y; Chen S; Yang K; Xia C; Peng S
J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
[TBL] [Abstract][Full Text] [Related]
12. Image Gallery: Kaposiform haemangioendothelioma.
Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
[No Abstract] [Full Text] [Related]
13. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: successful treatment with sirolimus.
Reichel A; Hamm H; Wiegering V; Wiewrodt B; Neubauer H; Ernestus K; Winkler B
J Dtsch Dermatol Ges; 2017 Mar; 15(3):329-331. PubMed ID: 28220608
[No Abstract] [Full Text] [Related]
14. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study.
Zhang G; Chen H; Gao Y; Liu Y; Wang J; Liu XY
Br J Dermatol; 2018 May; 178(5):1213-1214. PubMed ID: 29388191
[No Abstract] [Full Text] [Related]
15. First Intracardiac Kaposiform Hemangioendothelioma in an Infant Resolved With Sirolimus: A Case Report.
Zaidi SJ; Shaik S; Agrawal C; Cossor W
J Pediatr Hematol Oncol; 2018 Oct; 40(7):536-540. PubMed ID: 30067556
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus, a promising treatment for refractory Kaposiform hemangioendothelioma.
Kai L; Wang Z; Yao W; Dong K; Xiao X
J Cancer Res Clin Oncol; 2014 Mar; 140(3):471-6. PubMed ID: 24464150
[TBL] [Abstract][Full Text] [Related]
17. Role of Sirolimus in Advanced Kaposiform Hemangioendothelioma.
Oza VS; Mamlouk MD; Hess CP; Mathes EF; Frieden IJ
Pediatr Dermatol; 2016; 33(2):e88-92. PubMed ID: 26864138
[TBL] [Abstract][Full Text] [Related]
18. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
19. A Case Report of 2 Sirolimus-Related Deaths Among Infants With Kaposiform Hemangioendotheliomas.
Ying H; Qiao C; Yang X; Lin X
Pediatrics; 2018 Apr; 141(Suppl 5):S425-S429. PubMed ID: 29610165
[TBL] [Abstract][Full Text] [Related]
20.
Russell TB; Rinker EK; Dillingham CS; Givner LB; McLean TW
Pediatrics; 2018 Apr; 141(Suppl 5):S421-S424. PubMed ID: 29610164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]